Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)

Hospices Civils de Lyon4,000 enrolled

Overview

Prospective longitudinal cohort associated to blood collection, pathological samples collection, and radiological and pathological imaging collection.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

4,000

Conditions

Lung Cancer

Interventions

Blood sampleBIOLOGICAL

One optional veinous blood sampling (24 ML) between the first diagnostic annoucement and before the first treatment for lung cancer

QuestionnaireOTHER

to collect data not reported in the patient's medical file, such as passive smoking, family history of cancer, and attempts to quit smoking.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient treated for a thoracic cancer in the Lyon University Hospital: non-small cell lung cancer, small cell lung cancer, mesothelioma… * Diagnosis can be done: * By cytology or pathologic assessment * Or by multidisciplinary team meeting decision: * Irradiation without morpho-metabolic sampling * Treatment without sampling based on non-invasive molecular data Exclusion Criteria: \- Refusal to participate For optional blood sampling : * \< 30 kg for blood collection * No blood sampling schedule for care

Locations (1)

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

RECRUITING

Outcomes

Primary Outcomes

Number of participants registered in the lung cancer database

cohort open to recruitment during 10 years with 10 years of patients follow-up

Time frame: 20 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.